First U.S. patient receives autologous stem cell therapy to treat dry AMD

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

08/31/2022 02:45 PM EDT

Dry AMD is a leading cause of vision loss among older Americans.

This email was sent to linus.stotts.epicblog@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

Comments

Popular posts from this blog

The New REI + West Elm Collection Is Here!

U.S. Customs and Border Protection Media Releases Update

U.S. Customs and Border Protection Media Releases Update